Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
We defined erythropoietin (EPO) resistance by the ratio of the weekly EPO dose to hematocrit (Hct), yielding a continuously distributed variable (EPO/Hct). EPO resistance is usually attributed to iron or vitamin deficiency, hyperparathyroidism, aluminum toxicity, or inflammation. Activation of the acute-phase response, assessed by the level of the acute-phase C-reactive protein (CRP), correlates strongly with hypoalbuminemia and mortality in both hemodialysis (HD) and peritoneal dialysis (PD) patients. In this cross-sectional study of 92 HD and 36 PD patients, we examined the contribution of parathyroid hormone (PTH) levels, iron indices, aluminum levels, nutritional parameters (normalized protein catabolic rate [PCRn]), dialysis adequacy (Kt/V), and CRP to EPO/Hct. Albumin level serves as a measure of both nutrition and inflammation and was used as another independent variable. Serum albumin level (deltaR2 = 0.129; P < 0.001) and age (deltaR2 = 0.040; P = 0.040) were the best predictors of EPO/Hct in HD patients, and serum albumin (deltaR2 = 0.205; P = 0.002) and ferritin levels (deltaR2 = 0.132; P = 0.015) in PD patients. When albumin was excluded from the analysis, the best predictors of EPO/Hct were CRP (deltaR2 = 0.105; P = 0.003) and ferritin levels (deltaR2 = 0.051; P = 0.023) in HD patients and CRP level (deltaR2 = 0.141; P = 0.024) in PD patients. When both albumin and CRP were excluded from analysis in HD patients, low transferrin levels predicted high EPO/Hct (deltaR2 = 0.070; P = 0.011). EPO/Hct was independent of PTH and aluminum levels, PCRn, and Kt/V. High EPO/Hct occurred in the context of high ferritin and low transferrin levels, the pattern expected in the acute-phase response, not in iron deficiency. In well-dialyzed patients who were iron replete, the acute-phase response was the most important predictor of EPO resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These pathways ultimately culminate in an insufficient renal EPO response and hematopoietic EPO resistance further aggravating anemia in AI [95].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [95]
Citations
Cites
Progress in understanding the pathogenesis of the anemia of chronic disease [see comments]
Means, R. J., & Krantz, S. (1992) · Blood · doi:10.1182/blood.v80.7.1639.1639 · Cited by 681
Pereira, B. J. G., Shapiro, L., King, A. J., Falagas, M. E., Strom, J. A., & Dinarello, C. A. (1994) · Kidney International · doi:10.1038/ki.1994.117 · Cited by 384
Human disease, free radicals, and the oxidant/antioxidant balance
McCord, J. M. (1993) · Clinical Biochemistry · doi:10.1016/0009-9120(93)90111-i · Cited by 376
Determinants of albumin concentration in hemodialysis patients
Kaysen, G. A., Stevenson, F. T., & Depner, T. A. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90117-7 · Cited by 292
Self-citationElevated circulating levels of interleukin-6 in patients with chronic renal failure
Herbelin, A., Ureña, P., Nguyen, A. T., Zingraff, J., & Descamps-Latscha, B. (1991) · Kidney International · doi:10.1038/ki.1991.120 · Cited by 286
Ifudu, O., Feldman, J., & Friedman, E. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340702 · Cited by 253
Bárány, P., Divino Filho, J., & Bergström, J. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90339-5 · Cited by 244
Anemia in hemodialysis patients: variables affecting this outcome predictor.
Madore, F., Lowrie, E. G., Brugnara, C., Lew, N. L., Lazarus, J. M., Bridges, K., & Owen, W. F. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v8121921 · Cited by 243
Iron management in end-stage renal disease
Fishbane, S., & Maesaka, J. K. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90192-x · Cited by 174
Yeun, J. Y., & Kaysen, G. A. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90105-0 · Cited by 172
Self-citation
Research works printed but not linked: 4
- National Kidney Foundation Dialysis Outcomes Quality, 1997, Initiative clinical practice guidelines for the treatment of anemia of chronic renal failure, Am J Kidney Dis, 30, S192
- Bergström, 1995, Elevated serum CRP is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients, J Am Soc Nephrol, 6, 573
- Barth, 1995, Response to iron dextran therapy is not precluded by high serum ferritin, J Am Soc Nephrol, 6, 519
- National Kidney Foundation Dialysis Outcomes Quality, 1997, Initiative clinical practice guidelines for hemodialysis adequacy, Am J Kidney Dis, 30, S15
Cited by
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
Kalantar-Zadeh, K., Block, G., Humphreys, M. H., & Kopple, J. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00803.x · Cited by 1,247
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences
Kalantar-Zadeh, K., Ikizler, T. A., Block, G., Avram, M. M., & Kopple, J. D. (2003) · American Journal of Kidney Diseases · doi:10.1016/j.ajkd.2003.07.016 · Cited by 1,040
Kalantar-Zadeh, K., Kopple, J. D., Block, G., & Humphreys, M. H. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.29222 · Cited by 1,006
Kalantar-Zadeh, K., Kuwae, N., Regidor, D. L., Kovesdy, C. P., Kilpatrick, R. D., Shinaberger, C. S., McAllister, C. J., Budoff, M. J., Salusky, I. B., & Kopple, J. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001514 · Cited by 905
C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
Yeun, J. Y., Levine, R. A., Mantadilok, V., & Kaysen, G. A. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70200-9 · Cited by 887
Self-citation
Metadata
- Authors
- Gunnell, J., Yeun, J. Y., Depner, T. A., & Kaysen, G. A.
- Affiliations
- VA Northern California Health Care System (US)
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 1999-01
- Volume
- 33
- Issue
- 1
- Pages
- 63-72
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2084225019
- Cited by
- 305
- References
- 49
- Citations by year
- 2026: 1 · 2024: 6 · 2023: 1 · 2022: 4 · 2021: 8 · 2020: 6 · 2019: 7 · 2018: 1 · 2017: 5 · 2016: 8 · 2015: 8 · 2014: 10 · 2013: 19 · 2012: 8
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- American Journal of Kidney Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R0-1-DK 50777, R01DK050777)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- acute phase response, C-reactive protein, hemodialysis, peritoneal dialysis, serum albumin, ferritin, transferrin, iron deficiency, inflammation, anemia of chronic kidney disease, nutritional status, parathyroid hormone, aluminum toxicity, protein catabolic rate, dialysis adequacy
- MeSH terms
- Acute-Phase Reaction, Adult, Aged, Anemia, C-Reactive Protein, Dose-Response Relationship, Drug, Drug Resistance, Erythropoietin, Female, Renal Dialysis, Humans, Iron, Kidney Failure, Chronic, Male, Middle Aged, Peritoneal Dialysis, Prognosis, Regression Analysis, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. https://app.cochat.ai/papers/10.1016/s0272-6386(99)70259-3
- The paper
- Gunnell, J., Yeun, J. Y., Depner, T. A., & Kaysen, G. A. (1999). Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. American Journal of Kidney Diseases. https://doi.org/10.1016/s0272-6386(99)70259-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.